Abbott India Limited
ABBOTINDIA
Classifica tra le azioni
#3024
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Prezzo delle azioni
$285.88
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$6.07B
Variazione (1 giorno)
-1.13%
Variazione (1 anno)
-16.83%
Paese
IN
Scambia Abbott India Limited (ABBOTINDIA)
Categoria
Healthcare
Utile per Abbott India Limited (ABBOTINDIA)
Utile nel Jun 2026 TTM: $238.19M
Secondo gli ultimi rapporti finanziari di Abbott India Limited, gli utili attuali della società sono $238.19M. Nel 2024, la società ha registrato un utile di $194.01M, un aumento rispetto a agli utili del 2023, che erano di $155.00M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Abbott India Limited dal 2004 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $238.19M | 7.96% |
| 2025 | $220.63M | 13.72% |
| 2024 | $194.01M | 25.17% |
| 2023 | $155.00M | 8.97% |
| 2022 | $142.24M | 12.45% |
| 2021 | $126.49M | 18.71% |
| 2020 | $106.55M | 5.87% |
| 2019 | $100.64M | 5.44% |
| 2018 | $95.45M | 41.81% |
| 2017 | $67.31M | 12.04% |
| 2016 | $60.08M | 8.86% |
| 2015 | $55.19M | 39.00% |
| 2014 | $39.70M | 1.44% |
| 2012 | $39.14M | 15.33% |
| 2011 | $33.94M | 61.11% |
| 2010 | $21.06M | -16.67% |
| 2009 | $25.28M | 33.27% |
| 2008 | $18.97M | -26.36% |
| 2007 | $25.76M | 31.50% |
| 2006 | $19.59M | 3.19% |
| 2005 | $18.98M | -38.51% |
| 2004 | $30.87M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $33.60B | 14,004.37% |
US
|
|
| $17.74B | 7,346.49% |
US
|
|
| $8.70B | 3,552.08% |
US
|
|
| $5.95B | 2,397.14% |
US
|
|
| $21.39B | 8,879.40% |
CH
|
